Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50

Affiliations

• ¹ Centre Hospitalier Universitaire Nantes, Medical Oncology, Nantes University, 44000, Nantes, France. elvire.pons@chu-nantes.fr.
• ² Medical Oncology Unit, Clinique Mutualiste de L'Estuaire, Saint-Nazaire, France.
• ³ Centre Hospitalier Universitaire Nantes, Institute of Health and Medical Research, Santé Publique, Clinique Des Données, Inserm CIC 1413, Centre Hospitalier Universitaire de Nantes, Nantes University, 44000, Nantes, France.
• ⁴ Thoracic Oncology Department, Hôpital Larrey, CHU Toulouse, 31000, Toulouse, France.
• ⁵ Department of Medical Oncology, Comprehensive Cancer Center, Institut de Cancérologie de L'Ouest, Saint-Herblain, France.
• ⁶ Department of Pneumology, Centre François Baclesse, Caen, France.
• ⁷ Department of Pneumology, University Hospital of Bordeaux, Pessac, France.
• ⁸ Department of Medical Oncology, Hospital Foch, Suresnes, France.
• ⁹ Department of Respiratory Diseases and Thoracic Oncology, APHP-Hopital Ambroise Pare, 92100, Boulogne-Billancourt, France.